Corporate Events & Presentations

Please click here to be notified of all upcoming events.

Presentations

Date	Title
Sep 19, 2019	Add Files Corporate Presentation 1.7 MB

Archived Events

Date

Event Details

Sep 17 - 19, 2019

RAS-Targeted Drug Discovery Summit – Boston

Sep 8 - 10, 2019

21st Annual Global Investment Conference – NYC

Aug 14, 2019 at 9:00 AM EDT

Q2 2019 Onconova Therapeutics, Inc. Earnings Conference Call

Listen to Webcast

Jun 4, 2019 at 3:15 PM EDT

BIO International Forum, Philadelphia

Listen to webcast

Jun 4, 2019 at 8:20 AM PDT

9th Annual LD Micro Invitational

May 31, 2019

Acute Leukemia Forum China

May 14, 2019 at 9:00 AM EDT

Q1 2019 Onconova Therapeutics, Inc. Earnings Conference Call

Listen to webcast

Apr 8, 2019 at 10:10 AM BST

The 2019 HCW Global Life Sciences Conference

Listen to webcast

Mar 26, 2019 at 9:00 AM EDT

Q4 2018 Onconova Therapeutics, Inc. Earnings Conference Call

Listen to webcast

Feb 11, 2019 at 1:15 PM EST

BIO CEO & Investor Conference

Listen to webcast

Feb 7, 2019 at 8:00 AM EST

Advancements in the Treatment of Myelodysplastic Syndromes and Ras Mutated Lung Cancer (For more information, please refer to our Press Release of January 31)

Listen to webcast

KRAS+ Lung Cancer - R Veluswamy, MD, MSCR 1.8 MB

Advances in the Treatment of MDS 2019 - L Silverman, MD 5.7 MB

Onconova Summary - S Fruchtman, MD 341 KB

Jan 28 - 29, 2019

NobleCON 15th Annual Investor Conference

Location:

Fort Lauderdale, FL

Jan 7 - 10, 2019

J.P. Morgan Conference

View Additional Information

Meetings can be scheduled by contacting Suzanne Hutchison (shutchison@onconova.us)

Jan 6, 2019

China Focus@JPM Week

View Additional Information

Meetings can be scheduled by contacting Suzanne Hutchison (shutchison@onconova.us)

Nov 13, 2018 at 9:00 AM EST

Q3 2018 Onconova Therapeutics, Inc. Earnings Conference Call

Listen to webcast

Oct 18, 2018 at 11:00 AM PDT

Onconova Therapeutics To Present Update At The 2018 BIO Investor Forum In San Francisco

Bio Investor Forum Presentation 1.6 MB

View Additional Information

Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes (MDS), today announced that the Company will be presenting at the BIO Investor Forum, October 17-18, 2018, at the Westin St. Francis Hotel in San Francisco. Ramesh Kumar, CEO, will present at the conference and meet with investors.